Fact CheckerSign in

NCT05127382Active, not recruiting

Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

Osimertinib as First Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer: the Experience of the Hellenic Cooperative Oncology Group (HeCOG)

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

The present study will evaluate the use of osimertinib as 1st line therapy for patients with advanced EGFR positive non-small cell lung cancer who are treated at Hellenic Cooperative Oncology Group (HeCOG)-affiliated departments of oncology.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
9 Nov 2021
Start date
1 Feb 2020
Primary completion date
15 May 2026
Lead sponsor
Hellenic Cooperative Oncology Group
Diseases
Lung cancer
NCT number
NCT05127382

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 1 Feb 2020 to the primary completion date, 15 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • pretreated patients for NSCLC
  • patients that receive or are expected to receive or have received an investigational drug/product/intervention

Other illness

  • patients with cancer other than NSCLC that require treatment

Who the study is looking for

  • men or women of 18 years or older that live in Greece
  • histologically or cytologically confirmed, advanced EGFR positive non-small cell lung cancer
  • untreated patients for advanced NSCLC
  • patients who are expected to receive osimertinib regardless of their enrollment in the study
  • signed written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hellenic Cooperative Oncology Group
Coordinator of this site? Confirm its status
AthensGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.